IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bios Capital Management, LP

Q1 2025 Holdings

Filed 2025-05-14 | 9 holdings | $79.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Actuate Therapeutics Inc(ACTU)COM005083100$67.0M9,893,65184.6%
Lantern Pharma Inc(LTRN)COM51654W101$4.3M1,207,7095.4%
Rein Therapeutics Inc(RNTX)COM NEW00887A204$3.0M1,690,7513.8%
Cognition Therapeutics Inc(CGTX)COM19243B102$2.5M6,000,0003.2%
In8bio IncCOM45674E109$1.4M8,600,0011.8%
Opus Genetics Inc(IRD)COM67577R102$977.1K995,2491.2%